Findings in a recent study have proposed new target sites, which can be treated to help the body get rid of squamous cell lung cancer. The lung cancer is a form of non-small cell lung cancer; about 30% of the total cases are subjected to be squamous cell lung cancer.

This large genetical study of the common lung cancer type explains that almost 50% of the tumors can be treated using new drugs or those, which can be made easily.

The lung cancer claims an estimated 400,000 deaths annually around the world. People dying of the cancer types is more than that dying due to any other cancer type, except lung adenocarcinoma.

However, the major problem linked with this cancer is that it has no treatments, which target the genetic mutations, due to which it occurs.

Scientists at the Broad Institute, Dana-Farber Cancer Institute, and Harvard Medical School, who have led Cancer Genome Atlas (TCGA) Research Network, asserted that they have detected several sites, which can be targeted.

"This study clearly shows that squamous cell carcinoma, like lung adenocarcinoma, is a cancer with diverse genomic causes, many of which are potentially susceptible to drug inhibition", said Matthew Meyerson, co-leader of the project within TCGA. Thus providing with new and significant treatments for the cancer type.